Thursday, January 13, 2005

Merck seeks to take Mevacor over-the-counter

from Reuters:

Mevacor, known generically as lovastatin, lost patent protection in 2001. Selling an over-the-counter version could help Merck extend sales of the drug and also pave the way for a nonprescription version of the company's more widely used statin, Zocor. Zocor is sold without prescription in Britain.

0 Comments:

Post a Comment

<< Home